TickerStat.comEloxx Pharmaceuticals annual net profit margin
2010
2012
2013
2014
2024
Eloxx Pharmaceuticals Net Profit Margin Growth & History (ELOX)
Eloxx Pharmaceuticals's net profit margin was −49.43% for fiscal 2024.
View full Eloxx Pharmaceuticals company overviewEloxx Pharmaceuticals annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −49.43% | — |
| 2014 | 2014-06-30 | −5,062.44% | +73240.95 pp |
| 2013 | 2013-06-30 | −78,303.39% | −75770.32 pp |
| 2012 | 2012-06-30 | −2,533.07% | — |
| 2010 | 2010-06-30 | −9,559.65% | — |
Eloxx Pharmaceuticals quarterly net profit margin
Q2.12
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2012 | 2011-12-31 | −763.79% | — |
Eloxx Pharmaceuticals net profit margin trends
Between the periods ended 2010-06-30 and 2024-12-31, Eloxx Pharmaceuticals's net profit margin increased from −9,559.65% to −49.43%, a change of +9510.23 percentage points. The latest reported quarter, Q2 2012, shows −763.79%.
About the metric
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
Calculation and source
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Eloxx Pharmaceuticals source filings ↗Community posts
Eloxx doses first patients in mid-stage Alport syndrome trial
Eloxx Pharmaceuticals ($ELOX) dosed the first two patients in its Phase 2b EXACT study of exaluren for Alport syndrome caused by nonsense mutations. The trial plans to enroll 24 patients with relevant mutations in the COL4A3, COL4A4 or COL4 ...